Drug
GW 876008 clinical trials
Also written GW876008.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
- GW876008
- 7
Studies by the year they started
10 studies that test it; most in 2006 (6)
| Year | Studies |
|---|---|
| 2006 | 6 |
| 2007 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
NBI 77860 (2) · Paroxetine (1) · Lorazepam (1) · Midazolam (1)
Studies
Open first, then newest update. How each study uses GW 876008 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel SyndromeCompletedPhase 2GlaxoSmithKlineNCT00421707Written as GW876008
- Effects Of GW876008 On The Bowel In Patients With Irritable Bowel SyndromeCompletedPhase 2GlaxoSmithKlineNCT00385099Written as GW876008
- A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety DisorderCompletedPhase 1GlaxoSmithKlineNCT00555139Written as GW876008 tablet
- A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive PillsTerminatedPhase 1GlaxoSmithKlineNCT00508911Written as GW876008
- Treatment Of Patients With Social Anxiety DisorderCompletedPhase 2GlaxoSmithKlineNCT00397722Written as GW876008
- Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT00376896Written as GW876008 200mcg
- A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679WithdrawnPhase 2GlaxoSmithKlineNCT00511563Written as GW876008 and GSK561679
- A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.CompletedPhase 1GlaxoSmithKlineNCT00424697Written as GW876008
- An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.CompletedPhase 1GlaxoSmithKlineNCT00423761Written as GW876008
- A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.CompletedPhase 1GlaxoSmithKlineNCT00429728Written as GW876008